GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
TRY35.96bn
Enterprise Value
TRY36.46bn
Revenue
TRY14.74bn

Annual income statement for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,150	2,501	10,639	11,769	14,741
Cost of Revenue
Gross Profit	333	456	1,911	2,598	2,849
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,934	2,299	9,585	11,120	13,704
Operating Profit	216	203	1,055	650	1,037
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	217	301	501	379	421
Provision for Income Taxes
Net Income After Taxes	207	310	641	653	144
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	208	311	640	656	149
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	208	311	640	656	149
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.841	1.04	2.13	2.28	0.622
Dividends per Share